Effects of agmatine on the survival rate in rats bled to hemorrhage

Arzneimittel-Forschung/Drug Research

Volumn 61, Issue 4, 2011, Pages 229-233

  Gül, Fethi ^a   Pelit, Tuba ^a   Terzioǧlu, Berna ^a   Ekinci, Osman ^a   Gören, M Zafer ^b  

^a Haydarpasa Numune State Hospital   (Turkey)

^b MARMARA UNIVERSITY   (Turkey)

Author keywords

Hemorrhagic shock; L arginine; Nitric oxide (NO); Nitric oxide synthase inhibitor; Yohimbine

Indexed keywords

AGMATINE; AGMATINE SULFATE; ALPHA 2 ADRENERGIC RECEPTOR; ARGININE; NITRIC OXIDE; NITRIC OXIDE DONOR; SODIUM CHLORIDE; UNCLASSIFIED DRUG; URETHAN; YOHIMBINE;

ADRENERGIC ACTIVITY; ARTICLE; BLOOD PRESSURE REGULATION; DIASTOLIC BLOOD PRESSURE; DRUG EFFECT; HEART RATE; HEMORRHAGIC SHOCK; HUMAN; ILIAC ARTERY; ILIAC VEIN; MEAN ARTERIAL PRESSURE; NONHUMAN; RAT; SPRAGUE DAWLEY RAT; SURVIVAL RATE; SYSTOLIC BLOOD PRESSURE;

EID: 79955746954     PISSN: 00044172     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-0031-1296192     Document Type: Article

References (30)

1. Li G, Regunathan S, Barrow CJ, Eshraghi J, Cooper R, Reis DJ. Agmatine: an endogenous clonidine-displacing substance in the brain. Science. 1994;263:966-9. (Pubitemid 24094560)
2. Piletz JE, Chikkala DN, Ernsberger P. Comparison of the properties of agmatine and endogenous clonidine-displacing substance at imidazoline and alpha-2 adrenergic receptors. J Pharmacol Exp Ther. 1995;272:581-7.
3. Pinthong D, Hussain JF, Kendall DA, Wilson, VG. Comparison of the interaction of agmatine and crude methanolic extracts of bovine lung and brain with alpha 2-adrenoceptor binding sites. Br J Pharmacol. 1995; 115: 689-95.
4. Pinthong D, Wright IK, Hanmer C, Millns P, Mason R, Kendall DA, et al. Agmatine recognizes alpha 2-adrenoceptor binding sites but neither activates nor inhibits alpha 2-adrenoceptors. Naunyn Schmiedeberg's Arch Pharmacol. 1995 Jan;351(1):10-6.
5. Auguet M, Viossat I, Marin JG, Chabrier PE. Selective inhibition of inducible nitric oxide synthase by agmatine. Jpn J Pharmacol. 1995 Nov;69(3):285-7.
6. Galea E, Regunathan S, Eliopoulos V, Feinstein DL, Reis DJ. Inhibition of mammalian nitric oxide synthases by agmatine, an endogenous polyamine formed by decarboxylation of arginine. Biochem J. 1996;316:247-9.
7. Kolesnikov Y, Jain S, Pasternak GW. Modulation of opioid analgesia by agmatine. Eur J Pharmacol. 1996;296:17-22. (Pubitemid 26032232)
8. Fairbanks CA, Schreiber KL, Brewer KL, Yu CG, Stone LS, Kitto KF, et al. Agmatine reverses pain induced by inflammation, neuropathy, and spinal cord injury. Proc Natl Acad Sci USA. 2000 Sep; 12;97(19):10584-9.
9. Yananli H, Gören MZ, Berkman K, Aricioglu F. Effect of agmatine on brain l-citrulline production during morphine withdrawal in rats: A microdialysis study in nucleus accumbens. Brain Res. 2007 Feb;1132(1):51-8. (Pubitemid 46099006)
10. Lortie MJ, Novotny WF, Peterson OW, Vallon V, Malvey K, Mendonca M, et al. Agmatine, a bioactivemetabolite of arginine. Production, degradation, and functional effects in the kidney of the rat. J Clin Invest. 1996 Jan 15;97(2):413-20.
11. Gao Y, Gumusel B, Koves G, PrasadA, HaoQ,HymanA, et al. Agmatine: a novel endogenous vasodilator substance. Life Sci. 1995;57(8):83-6.
12. Ishikawa T, Misonou T, Ikeno M, Sato K, Sakamaki TN. Omega- hydroxyagmatine: a novel substance causing endothelium-dependent vasorelaxation. Biochem Biophys Res Commun. 1995 Sep;214(1):145-51.
13. Stuehr DJ, Kwon NS, Nathan CF, Griffith OW, Feldman PL, Wiseman J. N omega-hydroxy-L-arginine is an intermediate in the biosynthesis of nitric oxide from L-arginine. J Biol Chem. 1991 Apr 5;266(10):6259-63. (Pubitemid 21906212)
14. Yokoi I, Kabuto H, Habu H, Inada K, Toma J, Mori A. Structure- activity relationships of arginine analogues on nitric oxide synthase activity in the rat brain. Neuropharmacology. 1994 Nov;33(11):1261-5. (Pubitemid 24353717)
15. Komori Y, Wallace GC, Fukuto JM. Inhibition of purified nitric oxide synthase from rat cerebellumand macrophage by L-arginine analogs. Arch Biochem Biophys. 1994 Dec;315(2):213-8. (Pubitemid 24381536)
16. Senneguier N, Stuehr DJ. Analysis of substrate induced electronic, catalytic and structural changes in inducible NO synthase. Biochemistry. 1996;35:5883-92. (Pubitemid 26143682)
17. Hubbard JW, Pfister SL, Biediger AM, Herzig TM, Keeton KT. The pharmacokinetic properties of yohimbine in the conscious rat. Naunyn Schmiedeberg's Arch Pharmacol. 1988 May;337(5):583-7.
18. Jun T, Wennmalm A. L-Arginine-induced hypotension in the rat: evidence that NO synthesis is not involved. Acta Physiol Scand. 1994 Dec;152(4):385-90. (Pubitemid 24378027)
19. Collins JA, Braitberg A, Margraff HW, Butcher HR. Hemorrhagic shock in rats. Arch Surg. 1969 Oct;99(4):484-8.
20. Jurkiewicz NH, Garcez do Carmo L, Hirata H, da Costa Santos W, Jurkiewicz A. Functional properties of agmatine in rat vas deferens. Eur J Pharmacol. 1996 Jul 4;307(3):299-304.
21. Sun MK, Regunathan S, Reis DJ. Cardiovascular responses to agmatine, a clonidine-displacing substance, in anesthetized rat. Clin Exp Hypertens. 1995;17:115-28.
22. Szabo B, Urban R, Limberger N, Starke K. Cardiovascular effects of agmatine, a "clonidine-displacing substance", in conscious rabbits. Naunyn Schmiedeberg' Arch Pharmacol. 1995 Mar;351(3):268-73.
23. Raasch W, Schafer U, Qadri F, Dominiak P. Agmatine, an endogenous ligand at imidazoline binding sites, does not antagonize the clonidine-mediated blood pressure reaction. Br J Pharmacol. 2002 Feb;135(3):663-72. (Pubitemid 34177644)
24. Brian BH. Adrenoceptor-activating and other sympathomimetic drugs, Adrenoceptor antagonist drugs 10th ed. In: Katzung BR, editor. Basic and Clinical Pharmacology. Singapore: McGraw-Hill Education; 2007. p. 121-58.
25. Jackson EK, Gillespie DG, Zhu C, Ren J, Zacharia LC, Mi Z. Alpha2-adrenoceptors enhance angiotensin II-induced renal vasoconstriction: role for NADPH oxidase and RhoA. Hypertension. 2008 Mar;51(3):719-26. (Pubitemid 351301526)
26. Morrisey JJ, Klahr S. Agmatine activation of nitric oxide synthase in endothelial cells. Proc Assoc Am Physicians. 1997 Jan;109(1):51-7. (Pubitemid 27161049)
27. Regunathan S. Agmatine: biological role and therapeutic potentials in morphine analgesia and dependence. AAPS J. 2006 Jul 21;8(3):E479-84.
28. Yesilyurt O, Uzbay IT. Agmatine potentiates the analgesic effect of morphine by an a 2-adrenoceptor-mediated mechanism in mice. Neuropsychopharmacology. 2001 Jul;25(1): 98-103. (Pubitemid 32493826)
29. Uzbay IT, Yesilyurt O, Celik T, Ergün H, Isimer A. Effects of agmatine on ethanol withdrawal syndrome in rats. Behav Brain Res. 2000 Jan;107(1-2):153-9.
30. Dogrul A, Coskun I, Uzbay T. The contribution of alpha-1 and alpha-2 adrenoceptors in peripheral imidazoline and adrenoceptor agonist-induced nociception. Anesth Analg. 2006 Aug;103(2):471-7. (Pubitemid 44140655)